| Jacob Ha, FNP | |
|
300 Frederick Rd Ste 102, Catonsville, MD 21228-4682 | |
| (410) 650-9804 | |
| (410) 630-5546 |
| Full Name | Jacob Ha |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 300 Frederick Rd Ste 102, Catonsville, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295292407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R221233 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Good Samaritan Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
| Maryland Center For Arthritis And Regenerative Care Llc | 8325447337 | 2 |
News Archive
Almost half of all medicines globally are used irrationally. This, say medicines experts at the World Health Organization (WHO), can have severe consequences: adverse drug reactions, drug resistance, protracted illness and even death. In addition, the financial cost incurred by individuals and governments due to irrational use is unnecessary and often extremely high, particularly in developing countries where patients often pay for medicines out of pocket.
In a bold step to help its health plan members live healthier lives, Humana Inc. announced today that it will offer the Vitality wellness and loyalty program and the program's wide range of well-being tools and reward-partners through a joint venture with the program's parent, Discovery Holdings Ltd.
President Obama and Democratic and Republican congressional leaders reached a last-minute deal Friday to avoid a government shutdown. The agreement, which came after days of partisan sparring and rhetorical drama, would fund the government through the end of September and cut $78.5 billion compared to Obama's proposed but never enacted fiscal 2011 budget.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.
New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine.
› Verified 4 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171207001966 |
News Archive
Almost half of all medicines globally are used irrationally. This, say medicines experts at the World Health Organization (WHO), can have severe consequences: adverse drug reactions, drug resistance, protracted illness and even death. In addition, the financial cost incurred by individuals and governments due to irrational use is unnecessary and often extremely high, particularly in developing countries where patients often pay for medicines out of pocket.
In a bold step to help its health plan members live healthier lives, Humana Inc. announced today that it will offer the Vitality wellness and loyalty program and the program's wide range of well-being tools and reward-partners through a joint venture with the program's parent, Discovery Holdings Ltd.
President Obama and Democratic and Republican congressional leaders reached a last-minute deal Friday to avoid a government shutdown. The agreement, which came after days of partisan sparring and rhetorical drama, would fund the government through the end of September and cut $78.5 billion compared to Obama's proposed but never enacted fiscal 2011 budget.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.
New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine.
› Verified 4 days ago
| Entity Name | Maryland Center For Arthritis And Regenerative Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750963690 PECOS PAC ID: 8325447337 Enrollment ID: O20210525000846 |
News Archive
Almost half of all medicines globally are used irrationally. This, say medicines experts at the World Health Organization (WHO), can have severe consequences: adverse drug reactions, drug resistance, protracted illness and even death. In addition, the financial cost incurred by individuals and governments due to irrational use is unnecessary and often extremely high, particularly in developing countries where patients often pay for medicines out of pocket.
In a bold step to help its health plan members live healthier lives, Humana Inc. announced today that it will offer the Vitality wellness and loyalty program and the program's wide range of well-being tools and reward-partners through a joint venture with the program's parent, Discovery Holdings Ltd.
President Obama and Democratic and Republican congressional leaders reached a last-minute deal Friday to avoid a government shutdown. The agreement, which came after days of partisan sparring and rhetorical drama, would fund the government through the end of September and cut $78.5 billion compared to Obama's proposed but never enacted fiscal 2011 budget.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.
New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Ha, FNP 300 Frederick Rd Ste 102, Catonsville, MD 21228-4682 Ph: (410) 650-9804 | Jacob Ha, FNP 300 Frederick Rd Ste 102, Catonsville, MD 21228-4682 Ph: (410) 650-9804 |
News Archive
Almost half of all medicines globally are used irrationally. This, say medicines experts at the World Health Organization (WHO), can have severe consequences: adverse drug reactions, drug resistance, protracted illness and even death. In addition, the financial cost incurred by individuals and governments due to irrational use is unnecessary and often extremely high, particularly in developing countries where patients often pay for medicines out of pocket.
In a bold step to help its health plan members live healthier lives, Humana Inc. announced today that it will offer the Vitality wellness and loyalty program and the program's wide range of well-being tools and reward-partners through a joint venture with the program's parent, Discovery Holdings Ltd.
President Obama and Democratic and Republican congressional leaders reached a last-minute deal Friday to avoid a government shutdown. The agreement, which came after days of partisan sparring and rhetorical drama, would fund the government through the end of September and cut $78.5 billion compared to Obama's proposed but never enacted fiscal 2011 budget.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.
New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine.
› Verified 4 days ago
Mrs. Ija Lynn Delia, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 711 Maiden Choice Ln, Catonsville, MD 21228 Phone: 410-247-5602 Fax: 410-242-1756 | |
Joy C Odinammadu, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6400 Baltimore National Pike Ste 170a, Catonsville, MD 21228 Phone: 443-739-7947 | |
Belinda Okoruwa, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1000 Ingleside Ave, Catonsville, MD 21228 Phone: 443-551-3784 | |
Tiffany D Reabold, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 910 Frederick Rd, Catonsville, MD 21228 Phone: 410-644-1880 Fax: 410-646-3623 | |
Michele Kyle Bradshaw, Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 6120 Baltimore National Pike Ste 200, Catonsville, MD 21228 Phone: 301-291-5272 | |
Dr. Renada Lynn Gilliard, DNP, MS, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9 Turk Garth, Catonsville, MD 21228 Phone: 443-695-4433 | |
Assiatu B. Barrie, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 711 Maiden Choice Ln, Catonsville, MD 21228 Phone: 410-737-8838 |